This site is intended for UK Healthcare professionals only

Are you a UK Healthcare professional?

We are unfortunately unable to allow patients to attend DPC

If you would like more information on diabetes care, please refer to the NHS website.

Visit the NHS website?

DPC2021 Conference Programme



What is heart failure and how does it relate to diabetes?

10 Nov 2021
Heart & Kidney Clinic

Heart Failure and diabetes commonly co-exist and are associated with adverse outcomes. SGLT2 inhibitors are commonly used in diabetes to lower glucose but additionally reduce hospitalisation for heart failure in the same population. On the basis of recent evidence this group of drugs has also been shown to improve symptoms and reduce adverse outcomes in people with heart failure with and without diabetes.

  • 1. Diabetes and heart failure commonly co-exist
  • 2. Heart Failure is frequently present but undiagnosed in a diabetes population.
  • 3. Early diagnosis of heart failure is associated with improved long term outcomes
  • 4. SGLT2 inhibitors have benefits in both diabetes and heart failure


Diamond Sponsor

  • AstraZeneca


Platinum Sponsor

  • Abbott


Platinum Sponsor

  • Dexcom


Platinum Sponsor

  • Novo Nordisk


Platinum Sponsor

  • Viatris


Gold Sponsor

  • Eli Lilly


Gold Sponsor

  • Insulet


Silver Sponsor

  • Sanofi


Registration Sponsor

  • Viatris